Citations

Showing 10 of 108152 citations.

Commentary on: Industry Payments to Plastic Surgeons: What Has Changed Over the Last 6 Years Following Implementation of the Physician Payment Sunshine Act?
Bernard, Robert W.

Mayo Clinic

Aesthetic Surgery Journal | May 13, 2021 | Volume: 42 | Issue: 2 | Pages: 222-223

10.1093/asj/sjab160 | PMID 33982085 Get It

The Validity of Serum Alkaline Phosphatase to Identify Nutritional Rickets in Nigerian Children on a Calcium-Deprived Diet
Thacher, Tom D. , Sempos, Christopher T. , Durazo-Arvizú, Ramón , Fischer, Philip R. , Munns, Craig F. , Pettifor, John Μ. , Durazo-Arvizu, Ramon A , Pettifor, John M , Thacher, Thomas D , Fischer, Philip R

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | May 13, 2021 | Volume: 106 | Issue: 9 | Pages: e3559-e3564

10.1210/clinem/dgab328 | PMID 33982091 Get It

Abstract Context Nutritional rickets results from the interaction of low vitamin D status and limited calcium intake. Serum alkaline phosphatase (AP) activity is a biomarker of impaired mineralization in rickets. Objective To assess the performance of serum AP activity in identifying nutritional rickets in calcium-deprived Nigerian children. Methods We reanalyzed data from a case-control study of children with active rickets and matched control subjects without rickets, using a multivariate logistic regression to assess the odds of rickets associated with AP activity, adjusting for age, sex, and weight-for-age z-score. Results A total of 122 children with rickets and 119 controls were included. Rachitic children had a mean (±SD) age of 54 ± 29 months, and 55 (45.1%) were male. Cases and controls had low dietary calcium intakes (216 ± 87 and 214 ± 96 mg/day, respectively). Serum AP activity levels in cases and controls were 812 ± 415 and 245 ± 78 U/L, respectively (P < 0.001). AP was negatively associated with 25-hydroxyvitamin D values (r = −0.34; P < 0.001). In the adjusted model, the odds ratio (95% CI) receiver operating characteristic curve was 0.978. AP > 350 U/L identified nutritional rickets in Nigerian children with sensitivity 0.93, specificity 0.92, positive likelihood ratio 11.3, and negative likelihood ratio 0.07. Conclusion An AP > 350 U/L effectively discriminated between Nigerian children with and without nutritional rickets. AP is a low-cost biochemical test that could be used to screen for nutritional rickets, but cutoff values require validation in other populations, and laboratory values need to be standardized for widespread population studies.
Use of Community Based Participatory Research to Design Interventions for Healthy Lifestyle in an Alternative Learning Environment
Cristiani, Valeria, Kumbamu, Ashok , Asiedu, Gladys B. , Johnson, Shirley K., O’Brien, Janna R. Gewirtz , Ziebart, Gordon, Mogen, Melissa R., Lynch, Brian , Kumar, Seema

Mayo Clinic

Journal of Primary Care & Community Health | May 13, 2021 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/21501327211014749 | PMID 33980061 Get It

Introduction/Objectives Childhood obesity develops as the result of the interplay between individual and environmental factors. Community based participatory research (CBPR) is an effective tool for improving health of communities. There is limited research on CBPR for facilitating healthy lifestyle in community schools with an alternative learning environment. The objective of the study was to explore student and staff perspectives via focus groups on barriers and facilitators for healthy eating and physical activity in a community school with alternative learning environment and to prioritize, design, and implement suggested interventions to improve healthy lifestyle. Methods We conducted qualitative research through 8 focus groups of middle and high school students (n = 40) and 2 focus groups of school staff (n = 8). The school community and research team subsequently identified and implemented interventions for facilitating healthy lifestyle in students within the school environment. Results Barriers identified for healthy lifestyle included lack of motivation, lack of healthy food options at school, inadequate knowledge about healthy lifestyle and insufficient opportunities for physical activity. Facilitators for healthy lifestyle were support and motivation from mentors and knowledge about healthy nutrition. Key strategies implemented were addition of healthier food options, educational materials for healthy eating, creation of a walk path, standing desks in classrooms and additional equipment in the school gymnasium. Conclusions Formative feedback from students and staff was helpful in the implementation of strategies for facilitating healthy lifestyle among students within a community school with an alternative learning environment.
Severe tricuspid bioprosthetic valve stenosis as an unusual cause of pulmonary embolism: a case report
Naser, Jwan A. , Arghami, Arman , Eleid, Mackram F. , Pislaru, Sorin V. , Sabbah, Michael S. , Arghami, Arman , Naser, Jwan A

Mayo Clinic

European Heart Journal - Case Reports | May 13, 2021 | Volume: 5 | Issue: 5 | Pages: No page available

10.1093/ehjcr/ytab169 | PMID 34124568 Get It

Abstract Background Bioprosthetic tricuspid valve stenosis (TS) is an uncommon and frequently under-diagnosed condition. Although the resulting right heart failure symptoms are well-known, the associated thrombogenic potential is under-recognized. Case summary A 44-year-old woman with bioprosthetic tricuspid valve (TV) replacement in 2001 was referred for urgent consultation due to acute worsening of dyspnoea and severe swelling and pain in her left arm and neck. She was diagnosed with atrial fibrillation 6 months before the presentation and was found to have right atrial (RA) thrombus with pulmonary embolism and extensive retrograde venous extension 1 month prior. Review of studies done at her local institution revealed 10 mmHg mean gradient (MG) across the bioprosthetic TV that was only reported as mild–moderate TS. Echocardiography done at our instruction confirmed suspicion of severe TS with calcified immobile leaflets. Computed tomography showed persistent RA thrombus and therefore surgical replacement of the TV was undertaken. Subsequently, patient’s dyspnoea rapidly improved. Discussion Progressive dyspnoea and symptoms of right heart failure in a patient with a history of bioprosthetic TV replacement should be investigated for prosthetic valve dysfunction. Due to its rarity, TS diagnosis can be overlooked on routine echocardiography. In our patient, despite a measured MG of 10 mmHg, the presence of critical TS was not initially recognized. As TS is associated with increased thrombogenic potential and given the rare occurrence of in situ RA thrombosis, physicians must have a high index of suspicion for TS in the appropriate clinical context.
Multi‐institutional, prospective, randomized, double‐blind, placebo‐controlled phase IIb trial of the tumor lysate, particle‐loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high‐risk melanoma patients: A subgroup analysis
Chick, Robert C. , Faries, Mark B. , Hale, Diane F. , Hickerson, Annelies T. , Vreeland, Timothy J. , Myers, John W., Cindass, Jessica L., Brown, Tommy A., Hyngstrom, John , Berger, Adam C. , Jakub, James W. , Shaheen, Montaser , Park, Hyohyun, Sloan, Amanda JoEllen, Wagner, Thomas E., Peoples, George E. , Hickerson, Annelies T , Vreeland, Timothy J , Jakub, James W , Clifton, Guy T , Bohan, Phillip M. Kemp , Sussman, Jonathan , Clifton, Guy T.

Mayo Clinic

Cancer Medicine | May 13, 2021 | Volume: 10 | Issue: 13 | Pages: 4302-4311

10.1002/cam4.3969 | PMID 33982452 Get It

AbstractBackgroundCheckpoint inhibitors (CPI) in combination with cell‐based vaccines may produce synergistic antitumor immunity. The primary analysis of the randomized and blinded phase IIb trial in resected stage III/IV melanoma demonstrated TLPLDC is safe and improved 24‐month disease‐free survival (DFS) in the per treatment (PT) analysis. Here, we examine efficacy within pre‐specified and exploratory subgroups.MethodsStage III/IV patients rendered disease‐free by surgery were randomized 2:1 to TLPLDC vaccine versus placebo. The pre‐specified PT analysis included only patients completing the primary vaccine/placebo series at 6 months. Kaplan–Meier analysis was used to compare 24‐month DFS among subgroups.ResultsThere were no clinicopathologic differences between subgroups except stage IV patients were more likely to receive CPI. In stage IV patients, 24‐month DFS was 43% for vaccine versus 0% for placebo (p = 0.098) in the ITT analysis and 73% versus 0% (p = 0.002) in the PT analysis. There was no significant difference in 24‐month DFS when stratified by use of immunotherapy or CPI. For patients with resected recurrent disease, 24‐month DFS was 88.9% versus 33.3% (p = 0.013) in the PT analysis. All benefit from vaccination was in the PT analysis; no benefit was found in patients receiving up to three doses.ConclusionThe TLPLDC vaccine improved DFS in patients completing the primary vaccine series, particularly in the resected stage IV patients. The efficacy of the TLPLDC vaccine will be confirmed in a phase III study evaluating adjuvant TLPLDC + CPI versus Placebo + CPI in resected stage IV melanoma patients.
The regenerative effect of different growth factors and platelet lysate on meniscus cells and mesenchymal stromal cells and proof of concept with a functionalized meniscus implant
Hagmeijer, Michella H., Korpershoek, Jasmijn V. , Crispim, João F. , Chen, Li‐Ting , Krych, Aaron J. , Saris, Daniël B.F. , Vonk, Luciënne A. , Krych, Aaron J , Vonk, Lucienne A , Korpershoek, Jasmijn V , Jonkheijm, Pascal

Mayo Clinic

Journal of Tissue Engineering and Regenerative Medicine | May 13, 2021 | Volume: 15 | Issue: 7 | Pages: 648-659

10.1002/term.3218 | PMID 33982442 Get It

To Applied Clinical Informatics Authors and Reviewers: Thank You for All Your Help!
Lehmann, Christoph U. , Lehmann, Jenna S. , Petersen, Carolyn , Sittig, Dean F. , Sittig, Dean F , Lehmann, Christoph U , Petersen, Carolyn

Mayo Clinic

Applied Clinical Informatics | May 12, 2021 | Volume: 12 | Issue: 02 | Pages: 417-424

10.1055/s-0041-1729958 Get It

Infobuttons for Genomic Medicine: Requirements and Barriers
Connolly, John J. , Pet, Douglas , Peterson, Josh F. , Shirts, Brian H. , Starren, Justin , Walton, Nephi , Connolly, John J , Peterson, Josh F , Rasmussen, Luke V. , Fiol, Guilherme Del , Freimuth, Robert R. , Williams, Marc S , Taylor, Casey Overby

Mayo Clinic

Applied Clinical Informatics | May 12, 2021 | Volume: 12 | Issue: 02 | Pages: 383-390

10.1055/s-0041-1729164 | PMID 33979874 Get It

Abstract Objectives The study aimed to understand potential barriers to the adoption of health information technology projects that are released as free and open source software (FOSS). Methods We conducted a survey of research consortia participants engaged in genomic medicine implementation to assess perceived institutional barriers to the adoption of three systems: ClinGen electronic health record (EHR) Toolkit, DocUBuild, and MyResults.org. The survey included eight barriers from the Consolidated Framework for Implementation Research (CFIR), with additional barriers identified from a qualitative analysis of open-ended responses. Results We analyzed responses from 24 research consortia participants from 18 institutions. In total, 14 categories of perceived barriers were evaluated, which were consistent with other observed barriers to FOSS adoption. The most frequent perceived barriers included lack of adaptability of the system, lack of institutional priority to implement, lack of trialability, lack of advantage of alternative systems, and complexity. Conclusion In addition to understanding potential barriers, we recommend some strategies to address them (where possible), including considerations for genomic medicine. Overall, FOSS developers need to ensure systems are easy to trial and implement and need to clearly articulate benefits of their systems, especially when alternatives exist. Institutional champions will remain a critical component to prioritizing genomic medicine projects.
Feasibility of a single endoscopic plication procedure for the treatment of gastroesophageal reflux disease and obesity
Maselli, Daniel B. , Abusaleh, Rami , Trad, Karim S. , López-Nava, Gontrand, Turró, Román, Dayyeh, Barham K. Abu

Mayo Clinic

Endoscopy | May 12, 2021 | Volume: 54 | Issue: 05 | Pages: E203-E204

10.1055/a-1481-7844 | PMID 33979860 Get It

Impact of Palliative Care Services on Treatment and Resource Utilization for Hepatorenal Syndrome in the United States
Kaewput, Wisit , Petnak, Tananchai , O’Corragain, O.A., Cheungpasitporn, Wisit , Pattharanitima, Pattharawin , Lertjitbanjong, Ploypin , Kaewput, Wisit , Petnak, Tananchai , Cheungpasitporn, Wisit , Pattharanitima, Pattharawin , Thongprayoon, Charat , Boonpheng, Boonphiphop , Vallabhajosyula, Saraschandra , Qureshi, Fawad

Mayo Clinic

Medicines | May 12, 2021 | Volume: 8 | Issue: 5 | Pages: 21

10.3390/medicines8050021 | PMID 34065828 Get It

Background: This study aimed to determine the rates of inpatient palliative care service use and assess the impact of palliative care service use on in-hospital treatments and resource utilization in hospital admissions for hepatorenal syndrome. Methods: Using the National Inpatient Sample, hospital admissions with a primary diagnosis of hepatorenal syndrome were identified from 2003 through 2014. The primary outcome of interest was the temporal trend and predictors of inpatient palliative care service use. Logistic and linear regression was performed to assess the impact of inpatient palliative care service on in-hospital treatments and resource use. Results: Of 5571 hospital admissions for hepatorenal syndrome, palliative care services were used in 748 (13.4%) admissions. There was an increasing trend in the rate of palliative care service use, from 3.3% in 2003 to 21.1% in 2014 (p < 0.001). Older age, more recent year of hospitalization, acute liver failure, alcoholic cirrhosis, and hepatocellular carcinoma were predictive of increased palliative care service use, whereas race other than Caucasian, African American, and Hispanic and chronic kidney disease were predictive of decreased palliative care service use. Although hospital admission with palliative care service use had higher mortality, palliative care service was associated with lower use of invasive mechanical ventilation, blood product transfusion, paracentesis, renal replacement, vasopressor but higher DNR status. Palliative care services reduced mean length of hospital stay and hospitalization cost. Conclusion: Although there was a substantial increase in the use of palliative care service in hospitalizations for hepatorenal syndrome, inpatient palliative care service was still underutilized. The use of palliative care service was associated with reduced resource use.